Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06400550 · ClinicalTrials.gov registry record

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

A clinical trial of Melanoma (Skin), sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT06400550 is a study of Melanoma (Skin) that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 400 participants, above the 124-participant average among 30 other Melanoma (Skin) trials with a reported enrollment target (223% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06400550, a study of Melanoma (Skin), is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to observe metabolic features associated with human melanoma tumors.

Conditions Studied

Study Locations (1)

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2018-08-01
Est. Completion 2028-08-01

What the Registry Record Tells You About NCT06400550

The ClinicalTrials.gov registry entry for NCT06400550 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 124-participant average among 30 other Melanoma (Skin) trials with a reported enrollment target (223% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanoma (Skin) appearing as the primary indexed condition, and to 0 interventions.

NCT06400550 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06400550 about?

NCT06400550 is a clinical study titled "Identification of Metabolic Phenotypes Associated With Melanoma Metastasis". The goal of this study is to observe metabolic features associated with human melanoma tumors.

What is the current status of trial NCT06400550?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2018-08-01. Estimated completion is 2028-08-01.

What conditions does trial NCT06400550 study?

This clinical trial studies the following conditions: Melanoma (Skin).

Who is sponsoring clinical trial NCT06400550?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06400550 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Melanoma (Skin)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.